和肽素作为先天性心脏病术后围术期标志物的预后价值
本研究旨在评估和肽素在先天性心脏病患儿术后病程中作为生物标志物的适用性。研究纳入81例6岁以下接受体外循环手术的患儿,于围术期采集三次血样检测和肽素浓度变化。结果显示和肽素浓度在第一次与第二次、第一次与第三次采血间均显著升高(Ps < .001),且与体外循环时间、STS-EACTS死亡分类、正性肌力评分、机械通气时间、ICU及总住院时间呈正相关(r ≥ .27)。
要点
- 和肽素在先天性心脏病术后围术期显著升高
- 和肽素水平与手术复杂度和体外循环时间正相关
- 高和肽素水平提示更长机械通气、ICU及总住院时间
核心结论
- 和肽素显示出预测先天性心脏病术后患者临床结局的趋势。
- 和肽素水平较高的患者接受更复杂的手术、体外循环时间更长、需要更多儿茶酚胺支持、有创通气时间更长、总住院和ICU住院时间更长。
研究设计与样本
- 研究纳入81例6岁以下接受体外循环手术的先天性心脏病患者,围术期采集三次血样检测和肽素浓度变化。
- 主要结局终点为先天性心脏病患者体外循环术后围术期和肽素浓度的变化。
主要发现
- 第一次与第二次采血间以及第一次与第三次采血间和肽素浓度均显著升高(Ps < .001)。
- 体外循环时间、STS-EACTS死亡分类、正性肌力评分、机械通气时间、ICU住院时间、总住院时间与术前及ICU和肽素水平呈显著正相关(r ≥ .27)。
临床怎么用
- 和肽素可作为先天性心脏病术后围术期监测的潜在生物标志物,用于辅助评估手术复杂度和预后风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Copeptin is a cleavage product of vasopressin. This study aimed to figure out if copeptin would be a suitable biomarker in patients with congenital heart disease in the postoperative course. METHODS: The primary outcome endpoint of this study was the change in copeptin concentration perioperatively in patients with congenital heart disease after surgery, with the use of a cardiopulmonary bypass. Three blood samples were taken from 81 patients up to 6 years of age in order to evaluate changes in copeptin concentration. RESULTS: Significant increase of copeptin concentration was shown between the first and second blood draws as well as between the first and third blood draws (Ps < .001). Additionally, positive and significant correlations (r ≥ .27) between the cardiopulmonary bypass times, The Society of Thoracic Surgeons and European Association for Cardio-Thoracic Surgery mortality category, the inotropic score, the duration of mechanical ventilation, the length of stay at the intensive care unit (ICU), the length of stay at the hospital, and the preoperative as well as the ICU copeptin levels were found. CONCLUSIONS: Copeptin showed a tendency to predict the clinical outcome of patients after congenital heart surgery. Patients with higher copeptin levels underwent more complex procedures, had longer cardiopulmonary bypass times, required more catecholamine support, needed longer time of invasive ventilation, and had longer overall stay and ICU stay.
引用
- Urganci E, Marculescu R, Michel-Behnke I, et al. Copeptin: Prognostic Relevance as a Perioperative Marker in Pediatric Cardiac Surgery. Ann Thorac Surg. 2020. PMID: 33285135. doi:10.1016/j.athoracsur.2020.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。